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ABSTRACT
The objective of this study was to determine the frequency of occurrence and to characterize the typology of dysfluencies in individuals
with Parkinson’s disease (PD), including the variables age, gender, schooling, disease duration, score on the Hoehn and Yahr scale and
cognitive status (score on Mini-Mental State Examination). A cross-sectional study of a sample comprising 60 adults matched for gender,
age and schooling was conducted. Group I comprised 30 adults with idiopathic PD, and Group II comprised 30 healthy adults. For
assessment of fluency of speech, subjects were asked to utter a narrative based on a sequence of drawings and a transcription of 200
fluent syllables was performed to identify speech dysfluencies. PD patients exhibited a higher overall number of dysfluencies in speech
with a large number of atypical dysfluencies. Additionally, results showed an influence of the variables cognitive status, disease duration
and age on occurrence of dysfluencies.
Keywords: Parkinson’s disease, cognition, speech.
RESUMO
O objetivo deste estudo foi avaliar a frequência de ocorrência e caracterizar a tipologia das disfluências em indivíduos com doença de
Parkison (DP), controlando-se as variáveis, idade, sexo, escolaridade, tempo de doença, escore na escala de Hoehn e Yahr e status
cognitivo (escore no Exame do Minimental). Realizamos um estudo transversal com amostra composta por 60 adultos pareados por sexo,
idade e escolaridade. O grupo I foi formado por 30 adultos com DP idiopática, e o grupo II por 30 adultos sadios. Para a avaliação da
fluência da fala foi solicitada a emissão de uma narrativa a partir de uma sequência de figuras e realizada a trascrição de 200 sílabas para
verificação das disfluências de fala. Os pacientes com DP apresentaram um número maior de disfluências na fala com um grande número
de disfluências atípicas e, adicionalmente, observamos que houve interferência das variáveis status cognitivo, tempo de doença e idade na
ocorrência das disfluências.
Palavras-chave: doença de Parkinson, cognição, fala.
Parkinson’s disease (PD) is characterized by a degenera-
tion of neurons in the substantia nigra of the mesenceph-
alon, leading to a fall in dopamine production. Dysfunction
in the basal ganglia circuits is a determining factor in the
physiopathology of the classic signs, and hypokinetic dysar-
thria is commonly related to PD, with one of its symptoms
being impaired speech fluency1.
Neurogenic stuttering is an acquired disorder of speech
fluency secondary to a neuropathology identified in indivi-
duals with no history of fluency problems prior to the occur-
rence of the neurological disease2. Some studies have
reported that basal ganglia circuits play a key role in the
mechanisms of stuttering3,4. On the basis this relationship,
several studies were carried out examining the speech of
subjects with PD in an effort to characterize these fluency
disorders5,6,7,8. The dysfluencies described in individuals with
PD were: repetition and prolongation of first and last sylla-
bles of words, sound repetition, audible and inaudible blocks,
revisions and interjections4,5,7,8. Episodes of palilalia were also
observed, described as involuntary repetitions of syllable,
words or sentences9, a feature which appears much more
frequently than normally seen in developmental stuttering10.
Akin to any motor disorder however, these may have vari-
able characteristics regarding aspects of motor program-
ming and execution of articulatory gestures and may also
be influenced by some sociodemographic variables such as
age11and schooling12.
Therefore, the objective of this study was to determine
the frequency of occurrence and to characterize the typology
of dysfluencies, controlling for the variables age, gender,
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schooling, disease duration, score on the Hoehn and Yahr
scale and cognitive status (score on Mini-Mental State
Examination (MMSE)) in individuals with PD.
METHOD
This study was approved by the Research Ethics
Committee of the Universidade Federal de São Paulo (pro-
tocol number 0843\09). All participants signed a free and
informed consent form.
Casuistic
A cross-sectional study was conducted in a sample of
60 adults matched for gender, age and schooling: 30 adult
patients diagnosed with idiopathic PD attended at the
Sector for Motor Disorders of the Neurology Department
of the Universidade Federal de São Paulo, and 30 healthy
adults (control group) that were companions or family mem-
bers of the patients assessed.
The general inclusion criteria for both groups were as fol-
lows: age greater than or equal to 50 years; schooling greater
than or equal to 4 years; absence of personal or familial his-
tory of developmental or psychogenic stuttering; absence of
history of stroke or previous traumatic brain injury; absence
of alcoholism or use of illegal drugs; visual or hearing impair-
ments which could affect performance on the tasks given;
normal performance on the MMSE for educational level,
according to the standards established for the Brazilian
population13, to exclude subjects with dementia from the
sample and ensure that impairments in cognitive aspects
did not interfere with the specific assessment.
The patients participating in the study were diagnosed
with PD, had not undergone neurosurgery, were at stages
2, 2.5 or 3 on the Hoehn and Yahr14 scale, and in use of med-
ication for PD.
The control group consisted of healthy adult volunteers
who had less than 3% atypical dysfluencies or less than
10% typical fluencies in speech. These are cut off
values according the criteria of the Stuttering Severity
Instrument (SSI-3)15.
Procedures
All patients were followed by neurologists who con-
ducted both anamnesis and physical examinations.
For the assessment of fluency of speech and data collec-
tion for the sample, the study participants were asked to
produce a narrative based on a sequence of drawings consti-
tuting the (“The dog story”)16. The following task was eli-
cited from subjects: “Can you see this card. It is made up
of these seven drawings (examiner points to the drawings
in order). I want you to tell me the story you see in these
drawings. You can look at them for as long as you need
before starting.” The test commenced from the point the
individual started telling the story and finished when the
individual indicated they had nothing further to say.
In addition to the narrative, subjects were also asked to
describe a typical day in order to create a sufficient speech
sample for subsequent analysis.The instruction was “Please,
tell me everything that you normally do during the day”.
All patients were at the on phase of the medication dur-
ing the assessment.
Data collection was carried out on an individual basis.
The discourse produced was recorded using a digital camera
SONY Cyber – shot 6.0 mega pixels) and later transcribed.
Analysis of results
The criteria adopted for sample collection and analysis of
speech were those proposed in the Speech Fluency
Assessment Protocol17, applied to classify typology of breaks
into typical or atypical dysfluencies, based on transcription
of 200 expressed syllables. The definitions of the dysfluencies
proposed by the author are outlined below.
Typical dysfluencies: hesitations; interjections; revisions;
unfinished words; repetition of words, segments and sentences.
Atypical dysfluencies: repetitions of syllables; repetition of
sounds; prolongation; blocking; pauses (over two seconds)
and intrusions of sounds or segments.
Episodes of palilalia were also registered, characterized
by the presence of repetitions of syllables (over four times)
and words (over three times), with or without acceleration
of speech rate. Palilalia episodes were classified as atypical
dysfluency, since these are expected symptoms in PD
and do not figure in the speech of subjects without neuro-
logical disorders.
For analysis of the speech dysfluencies exhibited by the
PD and control groups, the absolute number of each dys-
fluency was computed for each individual, stratified into typ-
ical and atypical dysfluencies. Subsequently, the number of
typical, atypical and total (typical plus atypical) dysfluencies
exhibited by both groups was calculated and compared.
Speech rate was measured in words per minute and syl-
lables per minute. Means were calculated by dividing total
number of words or syllables by total sample time. The study
analysis entailed comparing the mean speech rates for the
PD and Control groups
Statistical analysis
Categorical data were compared using the Chi-squared
(x2) test (without Yates comparison) with application of
Fisher’s exact test when Cochran’s restrictions were present.
Student’s t-test for independent samples was employed
to compare means for continuous data, whereas Student’s
t-test for dependent sample was applied for paired samples.
Multiple linear regression analysis was performed to
check which variables had the greatest influence on typical
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and atypical dysfluencies (dependent variables). Age, gender,
schooling, disease duration, score on the Hoehn and Yahr
scale and score on the MMSE were preselected as independ-
ent variables. The step-wise forward method was used to
select independent variables for inclusion in the final model.
There was no missing data.
A probability (p) of less than 0.05 was considered statist-
ically significant and all tests were two-tailed. Differences
among means were calculated for a ninety-five percent con-
fidence interval (95%CI). All statistical analyses were carried
out using the software SPSS (Statistical Package for the
Social Science) version 11.5.1 for Windows.
RESULTS
Forty patients with PD attended at the Sector for Motor
Disorders of the Department of Neurology of the
Universidade Federal de São Paulo were scheduled for pho-
noaudiological assessments between September 2009 and
May 2010. Of this total, 10 were not included in the sample
because they did not attend the scheduled session. Thus, a
total of 30 patients followed the protocol, in addition to 30
controls. The data from these 60 subjects were considered
in the subsequent analyses.
General characteristics
The age of subjects in the sample ranged from 50 to 75 years,
with a mean age 62.3±7.0 years, and in terms of gender, 82%
were men. The general characteristics are shown in Table 1.
There were no statistically significant differences
between the Control group (CG) and the Parkinson’s disease
group (PDG) for age (62.4±6.9 versus 62.2±7.1 years;
t(58)=0.13; 95%CI=-3.4 to 3.9; p=0.898), schooling (8.7±4.2
versus 8.4±4.2 years; t(58)=0.21; 95%CI=-2.0 to 2.4; p=0.832).
Score on the MMSE (28.5±1.2 versus 28.4±1.4; t(58)=0.29;
95%CI=-0.6 to 0.8; p=0.770) or gender (83% versus 80%
men; x2(1)=0.11; p=0.739).
Clinical characteristics of PD patients
Disease duration ranged from 2 to 20 years (mean=9.9,
SD=4.4), 20% of patients had a score of 2 on the Hoehn
Table 1. Individual data of groups studied.
PDG CG
Age Schooling MEEM Drugs DD H & Y Age Schooling MEEM
1 66 12 30 C 13 3 50 8 27
2 58 5 27 C 8 3 52 10 29
3 73 8 27 S 12 3 64 15 30
4 66 4 27 S 2 2.5 55 4 29
5 66 5 27 C 12 3 75 15 29
6 58 4 26 C 15 2 75 8 30
7 59 4 27 C 11 3 63 15 29
8 59 5 28 C 4 2 69 4 28
9 64 11 30 C 10 2 70 4 28
10 58 4 25 C 9 2.5 63 4 26
11 66 8 30 S 12 2.5 55 11 30
12 68 15 29 C 4 2 69 5 28
13 65 15 30 C 2 2 62 15 29
14 52 4 27 C 8 2.5 52 11 29
15 75 12 30 C 11 3 65 15 30
16 73 4 29 C 10 2.5 67 4 25
17 60 15 29 C 10 2.5 67 4 26
18 55 15 29 C 10 2 67 4 29
19 68 15 29 C 6 2.5 69 5 29
20 65 4 28 S 4 2.5 60 8 29
21 52 10 30 C 12 3 56 8 28
22 66 15 30 C 10 2.5 60 8 30
23 56 5 28 C 6 2.5 60 4 27
24 68 8 29 S 8 2.5 54 15 29
25 70 11 30 C 20 3 55 8 29
26 50 8 28 C 14 3 60 8 29
27 53 4 27 C 17 3 72 12 29
28 50 11 29 S 18 3 68 4 28
29 69 4 28 C 8 3 60 12 29
30 58 8 29 C 10 3 59 12 28
PDG: Parkinson’s Disease Group; CG: Control Group; DD: Disease Duration; C: Combined Medication; S: Single Medication.
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and Yahr scale, 37% scored 2.5 and the remainder scored 3.
A total of 90% of the patients were in use of Levodopa,
37% Amantadine, 10% Selegiline, 60% Pramipexole and
13% Biperidene. Of the 30 patients in the sample, 24 (80%)
were in use of combined medications whereas 6 (20%) used
a single medication. Of the single users, five used levodopa
and one pramipexole.
Assessment of speech fluency
None of the subjects from the CG presented subjective
stuttering complaints whereas 63% of patients from the
PDG presented the complaint. This difference reached sig-
nificance: x2(1)=27.8; p,0.001.
The total number of dysfluencies found in the CG was
significantly lower than the number in the PDG (4.8±2.6 ver-
sus 8.9±6.7; t(58)=-3.12; 95%CI=-6.7 to 1.4; p=0.003), although
this difference was attributed to the number of atypical
(0.03±0.18 versus 4.53±5.71; t(58)=-4.31; 95%CI=-6.59 to
-2.41; p,0.001) and not to typical (4.6±2.6 versus 4.3±3.6;
t(58)=0.53; 95%CI=-1.2 to 2.1; p=0.598) dysfluencies.
Of the transcription of all of the syllables uttered (200
syllables uttered, free of breaks, plus dysfluent syllables),
the CG uttered an average of 7.97±5.25 extra syllables versus
14.53±15.28 in the PDG. This difference reached statistical
significance: t(58)=-2.23; 95%CI=-12.74 to -0.66; p=0.030.
However, the total of words expressed did not differ signific-
antly between groups (107.6±7.3 versus 112.6±15.4;
t(58)=-1.61; 95%CI=-11.27 to 1.20; p=0.112).
Table 2 shows the data of groups studied.
Speech rate
Concerning speech rate, measured by syllables or words
per minute, the CG was significantly faster than the PDG:
N 247.7±47.0 versus 216.0±57.8; t(58)=2.33; 95%CI=4.4 to 58.9;
p=0.023
N 129.4±28.0 versus 112.4±27.1; t(58)=2.39; 95%CI=2.8 to 31.2;
p=0.020
Influence of disease duration, cognitive status and
age on speech fluency
Multiple linear regression analysis was performed to check
which variables had the greatest influence on typical dysfluen-
cies (dependent variable). Age, gender, schooling, disease dura-
tion, score on the Hoehn and Yahr scale and score on the
MMSE were preselected as independent variables. The step-
wise forward method was used to select independent vari-
ables for inclusion in the final model (Table 3).
Table 2. Statistical data of groups studied concerning speech fluency.
CG PDG
Mean SD Minimun Maximun Median Mean SD Minimun Maximun Median
Hesitations 0.73 1.48 0 7 0 0.37 1.13 0 6 0
Intejections 2.3 2.17 0 9 2 1.97 2.17 0 9 1.5
Revisions 0.53 0.78 0 3 0 0.43 0.77 0 3 0
Unfinished words 0.17 0.46 0 2 0 0.1 0.31 0 1 0
Repetition of words 0.8 1.19 0 5 0 0.9 1.24 0 5 0
Repetition of segments 0.17 0.46 0 2 0 0.57 1.28 0 5 0
Repetition of sentences 0.07 0.25 0 1 0 0 0 0 0 0
Repetition of syllables 0.03 0.18 0 1 0 0.2 0.48 0 2 0
Repetition of sounds 0 0 0 0 0 0.07 0.37 0 2 0
Prolongations 0 0 0 0 0 0.23 0.57 0 2 0
Blocking 0 0 0 0 0 0.5 0.97 0 3 0
Intrusions of sounds 0 0 0 0 0 0.1 0.31 0 1 0
Pauses 0 0 0 0 0 0.93 1.66 0 8 0
Palilalia- words 0 0 0 0 0 0.97 2.34 0 8 0
Palilalia- syllabes 0 0 0 0 0 1.53 3.03 0 11 0
Total of syllabes 207.97 5.26 201 223 207 214.53 15.28 191 250 209.5
Total of words 107.57 7.29 94 121 108 112.6 15.43 89 155 110.5
Speech rate: syl/min 247.67 47.02 168.5 342.9 251.2 216 57.79 116 363.6 214.9
Spech rate: words/min 129.44 27.96 83.83 183.42 129.4 112.44 27.12 62.97 183.63 111.6
PD: Parkinson’s Disease Group; CG: Control Group; SD: Standard Deviation.
Table 3. Results of multiple linear regression analyses for typical dysfluencies.
Variables b Standard Error t 95%CI (b) p
Constant 7.38 1.56 - - -
Disease duration -0.31 0.14 -2.13 -0.61 to -0.01 0.042
Other variables: not selected
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Among the variables studied, the most relevant for typ-
ical dysfluency was disease duration: the longer the disease
duration, the fewer the number of typical dysfluencies found.
Multiple linear regression analysis was performed to
check which variables had the greatest influence on atypical
dysfluencies (dependent variable). Age, gender, schooling,
disease duration, score on the Hoehn and Yahr scale and
score on the MMSE were preselected as independent
variables. The step-wise forward method was used to
select independent variables for inclusion in the final
model (Table 4).
Among the variables studied, the most relevant for atypical
dysfluency were MMSE and age: the lower the MMSE score,
the greater the number of atypical dysfluencies; and the higher
the age, the greater the number of atypical dysfluencies.
DISCUSSION
The most important findings of this study were that PD
subjects had a significantly higher number of speech dysfluen-
cies overall compared to control subjects. Moreover, the ana-
lysis of number of typical and atypical dysfluencies revealed
an influence from the variables cognitive status, age and dis-
ease duration. All subjects in the PDG were dysarthric.
On characterising the overall number of dysfluencies, i.e.,
the sum of both typical and atypical dysfluencies, it was
found that the total number of dysfluencies presented by
the PDG was significantly higher than the number observed
in the CG. The difference between the groups was attributed
mainly to the number of atypical dysfluencies and not to
typical dysfluencies.
Based on this data, it is clear that typical dysfluencies, as
described previously, are dysfluencies which can be present
in the speech of any speaker in the absence of fluency
changes characterizing stuttering. As shown by the results,
the number of typical dysfluencies presented by the groups
was very similar, where the PDG had higher mean word
repetitions (up to two-fold higher) and segment repetitions.
This finding may possibly be explained by the presence of
the repetitive phenomena in the speech of the PD patients.
The age of the subjects studied may also have contribu-
ted to the number of typical dysfluencies found, since aging
is associated with increased hesitations and pauses in
speech, with interjection tending to be the most common
typical dysfluency11, a fact corroborated in the present study.
The data observed in this study revealed a predominance
of atypical dysfluencies in the speech of the PD patients. In
addition to palilalia, a condition extensively described in the
literature, long pauses, blocks and prolongation were also
found to be associated with the disease in the present study.
These symptoms have been reported by several other stud-
ies8,9, along with revisions and interjections8,18,19.
It is noteworthy to point out that all the patients in the
present study were in the on phase of their medication dur-
ing assessment. However, a number of studies in the literat-
ure have addressed the issues of use of medications for
movement improvement in PD and the fluency sequelae
induced, although no consensus has been reached among
studies on motor production of speech, with some showing
improvements20, and others deterioration6,8 in the on phase.
Concerning speech rate, another aspect of fluency ana-
lyzed, the CG was found to be significantly faster than the
PDG. The mean spontaneous speech rates found in the pre-
sent study however, proved higher than those found in an
earlier study21 of patients with different types of dysarthria.
In this case, the dysarthria could be a factor explaining this
difference in rates. The structures of the basal ganglia are
related with the function of initiating movements, and the
speech rate in patients with hypokinetic dysarthria can be
accelerated or slowed. In the cases of slowed rates, this
reduction in speed may be accompanied by bursts of accel-
erated speech22,23,24. While patients with more severe symp-
toms display abnormally slow or fast rates, patients with
mild PD have relatively normal speech rates25. Comparing
the two groups in the present study showed a lower speech
rate in the PD than in the CG. Thus, it appears that the
presence of episodes of accelerated speech rate, character-
ized as “speech bursts” in subjects with PD, together with
words and syllable repetitions – palilalia, do not translate
to a higher speech rate when this is calculated based on
words or syllables per minute and compared to healthy sub-
jects without neurological problems. Other notable factors
that may hamper the articulation of patients and conse-
quently slow speech rates include difficulty initiating the
movements needed for speech and muscle rigidity, although
the absence of severe patients in the current casuistic should
also be considered.
Table 4. Results of multiple linear regression analyses for atypical dysfluencies.
Variables b Standard Error t 95%CI (b) p
Constant 43.24 19.45 - - -
MMSE -2.04 0.71 -2.87 -3.49 to -0.58 0.008
Age 0.31 0.14 2.24 0.03 to 0.59 0.034
Other variables: not selected
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Among the variables studied, the most relevant for typ-
ical dysfluencies was disease duration (Table 3).
It was found that the longer the disease duration, the
fewer the number of typical dysfluencies observed. This
may be explained by the fact that as the disease evolves
and clinical condition deteriorates there is a predominance
of atypical dysfluencies in the speech of PD patients, with
typical dysfluencies becoming less evident.
With regard to atypical dysfluencies, the most relevant
variables were performance on the MMSE and age, since
the lower the MMSE score and the higher the age, the
greater the number of atypical dysfluencies in speech.
In fact, aging can also lead to greater typical dysfluencies
in the speech of healthy subjects11,26. while atypical dysfluen-
cies are less frequently observed. More specifically, in the
case of PD patients, older age was associated with more
atypical dysfluencies, strongly suggesting the occurrence of
this problem in the disease with greater likelihood of occur-
rence in older patients.
One of the criteria for inclusion of subjects in the study
was that score on the MMSE, adjusted for schooling, had
to lie within normal limits. Thus, subjects scoring less than
normative values were excluded from the study at the out-
set. The association between lower score on the MMSE
and a higher number of atypical dysfluencies suggests that
low schooling may have interfered in the results. Schooling
ranged from four to fifteen years of formal education where
MMSE cut-off scores are applied to participants based on
level of schooling, with lower cut-offs for individuals with
fewer years of schooling. Level of schooling of the subject
can impact both the organizing of discourse27, and oral pro-
duction12, contributing to dysfluencies28. The theory of inter-
action between worse performance on the MMSE and lower
level of schooling of the subjects also involves the question of
impact of schooling on the course of diseases. There is a
growing body of evidence suggesting that greater schooling
delays clinical onset and that a higher level of schooling
exerts a protective effect against neurological diseases29.
In conclusion, overall, the PD patients had a higher num-
ber of speech dysfluencies with an elevated number of atyp-
ical dysfluencies. Speech rate was slower in the PDG. The
variables cognitive status (MMSE), disease duration and
age had an influence on the occurrence of dysfluencies
and consequently on speech problems in patients with PD.
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